We are live on
!
Find out more
RG
Redmile Group Portfolio holdings
AUM
$1.51B
1-Year Est. Return
164.17%
This Fund
S&P 500
This Quarter
Est. Return
-1.62%
1 Year Est. Return
+164.17%
3 Year Est. Return
+929.47%
5 Year Est. Return
+823.75%
10 Year Est. Return
+18,826.17%
AUM
$2.99B
AUM Growth
-$537M
(-15%)
Cap. Flow
-$122M
Cap. Flow
% of AUM
-4.08%
Top 10 Holdings %
Top 10 Hldgs %
48.59%
Holding
90
New
10
Increased
29
Reduced
22
Closed
15
Top Buys
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$131M |
| 2 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
+$75.7M |
| 3 |
IGMS
IGM Biosciences
IGMS
|
+$63.5M |
| 4 |
ALLK
Allakos
ALLK
|
+$51.3M |
| 5 |
NVRO
NEVRO CORP.
NVRO
|
+$48.5M |
Top Sells
| 1 |
ARRY
Array Biopharma Inc
ARRY
|
+$405M |
| 2 |
eHealth
EHTH
|
+$76.5M |
| 3 |
Sarepta Therapeutics
SRPT
|
+$62.6M |
| 4 |
Elevance Health
ELV
|
+$51.8M |
| 5 |
UnitedHealth
UNH
|
+$34M |
Sector Composition
| 1 | Healthcare | 97.74% |
| 2 | Energy | 0.01% |
| 3 | Technology | 0% |
| 4 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALLK
1
DELISTED
Allakos
ALLK
| $242M | 8.1% |
3,077,128
+776,827
| +34% | +$51.3M |
|
|
FOLD
2
DELISTED
Amicus Therapeutics
FOLD
| $183M | 6.12% |
22,790,134
-2,500
| -0% | -$27.1K |
|
3
Fate Therapeutics
FATE
$336M
| $174M | 5.83% |
11,216,809
+857,143
| +8% | +$16.4M |
|
|
DCPH
4
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $162M | 5.43% |
4,780,898
+2,557,522
| +115% | +$75.7M |
|
|
ALDR
5
DELISTED
Alder Biopharmaceuticals
ALDR
| $155M | 5.2% |
8,244,896
| – | – |
|
6
argenx
ARGX
$54.1B
| $123M | 4.12% |
1,080,432
+11,600
| +1% | +$1.57M |
|
7
Bristol-Myers Squibb
BMY
$119B
| $114M | 3.82% |
2,252,600
+583,200
| +35% | +$27.4M |
|
|
ALXN
8
DELISTED
Alexion Pharmaceuticals
ALXN
| $114M | 3.81% |
+1,162,200
| New | +$131M |
|
9
uniQure
QURE
$2.78B
| $94.9M | 3.17% |
2,410,125
+740,600
| +44% | +$42.7M |
|
|
EPZM
10
DELISTED
Epizyme, Inc
EPZM
| $89.1M | 2.98% |
8,636,933
-92,209
| -1% | -$1.16M |
|
11
Regenxbio
RGNX
$622M
| $84.1M | 2.81% |
2,362,486
+971,110
| +70% | +$39.3M |
|
|
BOLD
12
DELISTED
Audentes Therapeutics, Inc
BOLD
| $83.2M | 2.79% |
2,962,655
-9,512
| -0.3% | -$325K |
|
13
Tandem Diabetes Care
TNDM
$1.07B
| $68.4M | 2.29% |
1,160,401
-5,631
| -0.5% | -$359K |
|
14
Wave Life Sciences
WVE
$1.15B
| $65.2M | 2.18% |
3,177,760
+458,053
| +17% | +$10.5M |
|
|
TCDA
15
DELISTED
Tricida, Inc. Common Stock
TCDA
| $64.1M | 2.15% |
2,077,700
+132,500
| +7% | +$4.44M |
|
16
Atara Biotherapeutics
ATRA
$76.8M
| $63.8M | 2.14% |
180,789
-3,248
| -2% | -$1.21M |
|
|
CELG
17
DELISTED
Celgene Corp
CELG
| $55.9M | 1.87% |
562,700
+5,700
| +1% | +$542K |
|
|
IGMS
18
DELISTED
IGM Biosciences
IGMS
| $55.8M | 1.87% |
+3,144,000
| New | +$63.5M |
|
|
NVRO
19
DELISTED
NEVRO CORP.
NVRO
| $55.4M | 1.85% |
643,864
+640,464
| +18,837% | +$48.5M |
|
|
WMGI
20
DELISTED
Wright Medical Group Inc
WMGI
| $49.6M | 1.66% |
2,404,157
+32,000
| +1% | +$762K |
|
21
DexCom
DXCM
$28.7B
| $45.4M | 1.52% |
1,216,632
+528,232
| +77% | +$20.5M |
|
|
SYRS
22
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $40.4M | 1.35% |
388,875
+26,837
| +7% | +$2.53M |
|
23
Penumbra
PEN
$12.5B
| $40.1M | 1.34% |
+297,972
| New | +$46.1M |
|
|
PRAH
24
DELISTED
PRA Health Sciences, Inc.
PRAH
| $39.2M | 1.31% |
+395,400
| New | +$39.3M |
|
25
Krystal Biotech
KRYS
$10.2B
| $37.4M | 1.25% |
1,078,300
-2,000
| -0.2% | -$89.4K |
|
Similar funds
ORI
GAI
HCMG
FMI
FCM
PP
AM
BFO